ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DXCM DexCom Inc

129.65
1.28 (1.00%)
After Hours
Last Updated: 00:27:58
Delayed by 15 minutes
Share Name Share Symbol Market Type
DexCom Inc NASDAQ:DXCM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.28 1.00% 129.65 129.04 129.77 129.94 127.79 128.66 1,858,417 00:27:58

Dexcom Promotes Quentin Blackford to Chief Operating Officer

17/09/2019 9:05pm

Business Wire


DexCom (NASDAQ:DXCM)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more DexCom Charts.

DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Quentin Blackford to the role of Chief Operating Officer (COO) in addition to his duties as Chief Financial Officer.

Mr. Blackford has served as Dexcom’s Executive Vice President and Chief Financial Officer since 2017. He has played a key role during one of the most significant periods of growth in the Company’s history, including the launch of Dexcom’s G6 system and the ongoing expansion of the Company’s manufacturing and business service operations. In his new role as COO, Quentin will oversee Dexcom’s worldwide supply chain, manufacturing operations, and expansion into new markets, better positioning the Company to fulfill its growth potential.

“We believe we are on the cusp of tremendous opportunities that will require discipline across our financial investments, resource allocation and business processes,” said Kevin Sayer, Chairman, President and Chief Executive Officer at Dexcom. “In light of this, we are expanding Quentin’s role to include oversight of global manufacturing operations, supply chain management and expansion into new markets. We believe this expanded role will allow for better coordination across key business units that are critical to the realization of these opportunities.”

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes.

DexCom, Inc.: Steven R. Pacelli Executive Vice President, Strategy and Corporate Development (858) 200-0200 www.dexcom.com

1 Year DexCom Chart

1 Year DexCom Chart

1 Month DexCom Chart

1 Month DexCom Chart

Your Recent History

Delayed Upgrade Clock